(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SKYCOVIONE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SKYCOVIONE

ST13

US500000079329154

Class

5

Filing

79329154

Registration

7088836

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

09/27/2025

Trademark type

Word

Nice classes

5

Filing date

11/23/2021

Registration date

06/27/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/27/2023

Last transaction

09/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

LEE, DOUGLAS

Current location

Historical data usage

Holders and representatives

Holders

SK bioscience Co., Ltd.

Representatives

Hun Joon Kim LEX IP Meister, PLLC.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposesfor the treatment of respiratory infectious diseases and disorders; Veterinary preparations for the treatment of respiratory diseases and disorders; Drugs for medical purposesfor treating viral infections and respiratory diseases and disorders; Pharmaceuticals for human purposesfor treating viral infections and respiratory diseases and disorders; vaccines; * used for prophylactic and therapeutic treatments for infections of Sarbecovirusincluding SARS-CoV-1SARS-CoV-2any other coronavirus and any variant thereof. * veterinary vaccines; viral vaccines; human vaccine preparations; vaccines against pneumococcal infections; Medical diagnostic reagents for medical usenamely for detecting immunization disease; diagnostic agents for pharmaceutical use; * pharmaceutical products for the treatment of infectious diseases namely prophylactic and therapeutic treatments for infections of Sarbecovirusincluding SARS-CoV-1SARS-CoV-2any other coronavirus and any variant thereof * ; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; antiviral agents; immunotherapeutic agents for bacterial infections; bacterial preparations for medical purposes; reagents for use in diagnostic tests for medical purposes; sterilizing washes; disinfectants for chemical toilets; Medical diagnostic test strips for blood analysisurine analysissaliva analysisnasal secretion analysis

Publications

History of USPTO decisions and trademark events.

42 publications found

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

09/26/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/27/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/27/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/27/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/27/2024

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

07/03/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

07/02/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/02/2024

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

03/16/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/24/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/29/2023

FIMP

FINAL DISPOSITION PROCESSED

09/29/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/27/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/27/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/27/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/24/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/24/2023

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/22/2023

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

02/08/2023

GPNX

NOTIFICATION PROCESSED BY IB

01/24/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/10/2023

PUBO

PUBLISHED FOR OPPOSITION

01/10/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/04/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/04/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/21/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/05/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/29/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/28/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/28/2022

ATRV

ATTORNEY REVIEW COMPLETED

07/21/2022

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

07/19/2022

RFNT

REFUSAL PROCESSED BY IB

06/22/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/28/2022

RFRR

REFUSAL PROCESSED BY MPU

05/28/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/26/2022

CNRT

NON-FINAL ACTION WRITTEN

04/25/2022

DOCK

ASSIGNED TO EXAMINER

04/19/2022

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/12/2022

MAFR

APPLICATION FILING RECEIPT MAILED

01/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/04/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/23/2021

Continuous trademark protection

Get notified about every new filing that threatens SKYCOVIONE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.